Decatur Capital Management, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1505961 Decatur, GA

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,168,226

+$222,652 QoQ

Shares Held

4,365

+0.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.75%

of 13F equity value

Holder Rank

#656

of 1,735 holders

Holding Since

Jun 2020

19 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Decatur Capital Management, Inc. holds $2,168,226 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,365	$2,168,226

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,168,226	4,365	+0.2%	Shares	Sole	2026-08-14
2026-03-31	$1,945,574	4,357	-1.6%	Shares	Sole	2026-05-13
2025-12-31	$2,006,571	4,426	-5.1%	Shares	Sole	2026-02-11
2025-09-30	$1,826,608	4,664	+0.6%	Shares	Sole	2025-11-13
2025-06-30	$2,064,837	4,638	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,248,595	4,638	+0.2%	Shares	Sole	2025-05-14
2024-12-31	$1,863,695	4,628	-1.4%	Shares	Sole	2025-02-13
2024-09-30	$2,183,550	4,695	-47.3%	Shares	Sole	2024-11-26
2024-06-30	$4,172,076	8,901	+2.5%	Shares	Sole	2024-08-14
2024-03-31	$3,628,326	8,680	-1.0%	Shares	Sole	2024-05-15
2023-12-31	$3,567,611	8,768	+46.4%	Shares	Sole	2024-02-14
2023-09-30	$2,082,267	5,988	0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,107,237	5,988	-1.2%	Shares	Sole	2023-08-09
2023-03-31	$1,908,694	6,058	-13.9%	Shares	Sole	2023-05-09
2022-12-31	$2,030,700	7,032	-33.0%	Shares	Sole	2023-01-26
2021-03-31	$2,255,270	10,495	-47.4%	Shares	Sole	2021-05-06
2020-12-31	$4,719,237	19,968	-2.1%	Shares	Sole	2021-01-28
2020-09-30	$5,549,343	20,393	+23.4%	Shares	Sole	2020-11-03
2020-06-30	$4,798,243	16,528	—	Shares	Sole	2020-08-04
No filing history on record for this holder in this stock.